Categories: >>

Health

Updates

• British Scientists "Invent Around" Protections on Patented Drug
• Eli Lilly Patent Decision Upheld
• Heightened Activity on Greater Open Access to Scientific Research for Disadvantaged Nations
• Thailand Pursues Compulsory License for Anti-AIDS Drug
• "Philadelphia Consensus Statement" Calls upon WHO, Academia, to Bolster Poor Nations' Benefits from Health Research
• U.S. Commerce Secretary: China Must Strengthen Copyright Infringement Laws
• WTO Director-General Calls Upon Poor Nations to Enact Compulsory Licensing for Critical Patented Drugs
• USPTO to Re-examine Basis for Three Patents on Human Embryonic Stem Cells
• New India-based Initiative to Oppose Patenting of HIV Medications
• Generic Copy of Anti-clotting Drug Forced Off of Market in U.S.
• Generic Drug-maker Challenges Patent
• Canada Institutes Humanitarian Endeavor to Make Information and Medicine More Easily Available to Impoverished Countries
• Federal Trade Commission Weighs in on Access to Generic Drugs
• Pharmaceutical Company Refuses to Market Drug Over Price Disagreement
• Korea Reforms Health Insurance Policy, Tightens Funding for Multinational Drug Companies
• Late Patent Extension Request Spurs Proposed Legislation in House
• US-Morocco FTA Provisions for Intellectual Property Rules Draw Attention from the United Nations
• FDA Approves a "Biosimilar" Copy of a Biotechnology-Derived Drug
• Brazil Seeks to Apply Traditional Knowledge for Pharmaceutical Purposes, Prevention of Biopiracy
• WHO to Study Effects of International Drug Patent System on Low-Income Nations
• Gilead Sciences' Plan for Non-exclusive Licensing of AIDS Drug Met with Mixed Reactions
• Patent Dispute Arises From Discovery Made Over 20 Years Ago
• FTC Reports on Legal Settlements to Generic Drug Manufacturers
• April 26: Sixth World Intellectual Property Day Observed With Activities Throughout the World
• New Trade Association Analysis: Generic Forms of Widely-used Drugs Face Challenges in the Marketplace
• Heavy Volume of Patent Applications Before FDA's Office of Generic Drugs Could Bolster Profits of Name-brand Drug Producers
• Patenting of AIDS Drug in India Meets Legal Resistance
• Sanofi-Aventis and Bristol-Myers Squibb Reach Settlement on Patent for Well-Known Blood Thinner
• Tuesday, March 21: Landmark Patent Case Before Supreme Court
• Patent Status as a Factor in Drug Pricing?
• Cleveland Clinic Grants Exclusive Rights to Company to Advance Therapy for Damaged Hearts
• U.S.-Thai Trade Talks Muddled Over Intellectual Property Rights Provisions
• Approval Process for Biotech-derived Generic Drugs Not Yet Established
• Amendment to WTO's Intellectual Property Rules Eases Poor Countries' Access to Generic Drugs
• WTO Grants Poorest Nations Less Time than Requested to Adhere to International Intellectual Property Rules
• Kucinich, 12 House Democrats Object to Proposed Privatization of Open Access Scientific Journal
• China Second only to U.S. in Ownership of Health-Based Nanotechnology Patents
• BioShield II Legislation Closer to Compromise on Drug Patenting
• Representative Brown Introduces Bill to Enact Compulsory Licensing During Healthcare Crises
• Senator Schumer Calls for “Immediate Licensing” to Allow U.S. Manufacturers to Produce the Antiviral Drug Tamiflu
• European Commission Remains Vague on Biotechnology Patenting; Industry Disappointed
• South Centre and CIEL: Quarterly Update on IP and Development
• Emory Sells AIDS Drug Rights for Record $525 Million
• Brazil and Abbott Reach Deal on Kaletra
• Brazil May Break Patent on HIV/AIDS Drug
• ETC Reports on Impact of Nanotechnology Patents for Global South
• Supreme Court Interprets Broader Exemption for Drug Research
• WHO Holds Workshop and Open Forum on IP, Innovation and Health
• Brazil’s Lower House Votes to Suspend AIDS Drug Patents
• WHO Studies on IP and Health Available Online
• Wellcome Trust Announces Six Month Open Access Policy
• Debate on Bioshield II Patent Provisions at Center for American Progress
• Celera Will Make DNA Information Free
• Israeli Scientist's AIDS Discovery Languishes in IP Disputes
• Merck v. Integra Briefs Available Online
• Senators Propose Patent Extensions to Spur Biodefense R&D
• Database of Traditional Tibetan Drugs Goes Online
• Amicus Brief on Research Exemption Submitted to Supreme Court
• Proposed Medical R&D Treaty Would Provide Alternative Incentives for Innovation
• OECD Issues Draft Guidelines for Licensing Genetic Inventions
• NIH Asks Grantees to Voluntarily Release Published Articles
• Brazil Reshapes Debate on Intellectual Property
• US Pressures Guatemala to Revise Data Protection Law
• Supreme Court Will Hear Merck v. Integra
• NIH Open Access Publishing Policy Release Postponed
• World Bank Releases Two Books on IP and Development
• April 2005: WIPO Meeting on Establishing a Development Agenda
• Germany Passes New Biotech Patent Law
• New Open Access Initiative from Publishers and Advocacy Groups
• WHO Initiates 23 Studies on IPRs, Innovation and Public Health
• GSK Tells Blair to Press G8 for Patent Reform
• Guatemala Repeals Data Exclusivity Rule
• Epogen Patent Ruling: UK Will Not Allow Overly Broad Claims
• European Commission Proposes Generic Export Regulation
• NAS Committee on IPRs in Genetic and Protein-Related Inventions: Meeting Transcript and Presentations Available
• “Innovation Sails Free”: Newsweek Article on Open Source Science
• Greenpeace Challenges Stem Cell Patent
• UK Court Revokes Amgen Patent
• Drug Maker Promotes Generics for Workers
• Venture Capitalists Support CA Stem Cell Initiative
• Judge Rules for Amgen Patents
• Digene Settles Patent Dispute over HPV Test
• Genomics and Public Health: New Report on Science for the MDGs
• Patents in Pharmaceutical R&D: Discussion in Bulletin of the WHO
• Open Source Biotech Starts in Earnest
• Samoa to Profit from Indigenous Knowledge Deal
• Funding Pharmaceutical R&D: Alternatives to the Patent System
• Biomedical R&D Funders Requiring Collaboration
• GSK Licenses AIDS Drugs in Kenya
• Zambia Issues Compulsory License for AIDS Drug
• Expiring Patents Drive Drug Companies to Merge
• Pubpat Challenges Pfizer's Lipitor Patent
• China Considering Compulsory Licenses for AIDS Drugs
• Chiron Settles HIV Test Patent Dispute With Roche
• Medical Journals Require Drug Trials to be Made Public
• NIH Requests Comments on Open Access Policy
• Rep. Istook to Discuss Open Access on House Floor
• ALRC Recommends Gene Patenting Changes for Australia
• NIH Proceeds With Plan to Provide Open Access to Scientific Papers
• AIDS Drugs: Is Patent the Obstacle?
• Vermont Sues FDA Over Drug Reimportation
• Congressman Brown Asks Thompson to Reverse NIH Norvir Decision
• Traditional Medicines Must Be Registered and Studied
• Federal Stem Cell Lines Declared "Suitable" for Research
• Britain allows cloning of human cells for research
• FDA Warns of Terrorist Drug Tampering
• NIH Decides Not to Intervene on Norvir Pricing
• Merck Licenses AIDS Drug to South African Generic Manufacturer
• Poor Countries Can Import Generics Without E.U. Rule
• Chinese Challenge Diabetes Drug Patent
• NIH Director Meets with Publishers on Open Access
• Open Access Language Appears in NIH Appropriations Report
• AIDS Healthcare Foundation Drops Norvir Lawsuits
• Language Barrier Slows Access to Generic Drugs
• Text of U.S. Representatives' Letter on FTAs
• WHO Solicits Comments on IP and Health Plan
• Free Access to NIH-Funded Research Recommended by House Appropriations Committee
• AHF and Abbott settle
• Congress Approves Project BioShield
• Government to Open "Stem Cell Bank"
• China Overturns Viagra Patent
• Drug Companies Try to Improve Public Image
• Pfizer Expands Discount Drug Progam
• World Health Organization Proposes Global Drug Trial Registry
• Texas Medical Association Backs Stem Cell Research
• Generic 3-in-1 AIDS Pill Effective in Study
• Mylan Sues FDA Over Generic Pain-Relief Patch
• Draft text of US-Bahrain Free Trade Agreement
• Kerry Supports Further Stem Cell Research
• Open-Source Drug Discovery Proposed for Neglected Diseases
• Fifty-Eight Senators Urge Pres. Bush to Expand Stem Cell Policy
• Sen. Gregg Introduces FDA-Approved Bill for Drug Importation
• Aetna Drops Antitrust Suit Against Abbott
• Central American Free Trade Agreement (CAFTA) and U.S.-Bahrain FTA
• Both Sides Speak Out at Norvir March-In Meeting
• Thailand To Give Free AIDS Drugs To Other Countries
• Speakers for NIH May 25 Norvir March-in meeting
• Sens Hollings, McCain, and Schumer ask FTC to inquire into Norvir price increase
• Breast Cancer Gene Patent Revoked in Europe
• PLoS Launches Open Access Medical Journal
• HHS Attempting to Ensure Rapid Delivery of ARV's
• Patent Office Grants PUBPAT Request To Reexamine Cotransformation Patent
• Six House Republicans Ask for Hearings on Norvir Pricing
• AAAS Supports Policy Push for Broader Access to New Human Embryonic Stem Cell Lines
• HHS Sec. Declares Drug Importation "Helpful, Inevitable"
• New Case Against Abbott Laboratories
• China Announces Free AIDS Drugs and Testing
• Federal Hearing on Importing Cheaper Drugs
• Federal hearing on importing cheaper drugs
• Appeals Ruling Could Impact Combination Drug Development
• WTO to host public symposium on the Doha Agenda
• New Deal reached by Coalition to provide AIDS drugs to poor
• Patent threat to anti-HIV compounds is lifted
• WHO launches intellectual property commission

Legislation

• Pharmaceutical Market Access and Drug Safety Act of 2004
• Stem Cell Research Enhancement Act of 2004
• Reliable Entry for Medicines at Everyday Discounts through Importation with Effective Safeguards Act of 2004 (REMEDIES Act)
• Greater Access to Affordable Pharmaceuticals Act
• Greater Access to Affordable Pharmaceuticals Act (S 1225)

Hearings

Publications

• A Fair Deal for the Future: Flexibilities Under TRIPS
• Financing Drug Research: What are the Issues?
• Genes and Ingenuity: Gene Patenting and Human Health
• Has the Implementation of the TRIPS Agreement in Latin America and the Caribbean Produced Intellectual Property Legislation that Favours Public Health?
• Integrating Intellectual Property Rights and Development
• Open Access and the Public Domain in Digital Data and Information for Science: Proceedings of an International Symposium
• Ownership of knowledge - the role of patents in pharmaceutical R&D
• SPARC Letter to NIH on Open Access
• Scientific Publications: Free for All?
• Traditional Knowledge and Intellectual Property

Meetings

• 17 Jan 2007 10:00: Hearing: Paying off Generics to Prevent Competition with Brand Name Drugs
• 26 Jun 2006 9:00: Secretary's Advisory Committee on Genetics, Health, and Society: 10th Meeting
• 27 May 2005 8:30: Gene Patents and Public Health
• 21 Apr 2005 13:30: Bridging the Divide 2005 : Technology, Innovation and Learning in Developing Economies
• 25 Oct 2004 8:30: Global Challenges for Guiding and Managing Biological Technologies - meeting of the NAS Board on Agriculture and Natural Resources
• 20 Oct 2004 12:00: Gene Patenting and Human Health - Lunchtime Talk
• 4 Oct 2004: BIO IP Counsel Committee Meeting
• 18 Sep 2004: Patent Policy: Using, Abusing and Reforming
• 5 Aug 2004 8:00: National Academies: IP in Genomic and Protein Research and Innovation
• 4 Jun 2004: Public Workshop: Intellectual Property Rights in Genomic and Protein-Related Inventions
• 25 May 2004 9:00: NIH Norvir March-in Meeting
• 25 May 2004: Multilateralism at a Crossroads: WTO annual public symposium
• 5 May 2004 10:00: Fifth listening session on drug importation